Structure/activity relationships of C‐terminal neuropeptide Y peptide segments and analogues composed of sequence 1–4 linked to 25–36
Annette G. Beck‐Sickinger(Leipzig University of Applied Sciences), R. E. Lang(Heidelberg University), Gerd Schnorrenberg(Boehringer Ingelheim (Germany)), Wolfram Gaida(Boehringer Ingelheim (Germany)), Herbert Köppen(Boehringer Ingelheim (Germany)), Günther Jung(University of Tübingen)
Cited by 47
Related Papers
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
|Pharmacological Reviews|1998|893
GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin
|Endocrinology|2006|432
Herbal drugs and phytopharmaceuticals
|Pharmaceutica Acta Helvetiae|1995|415
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
|European Journal of Pharmacology|1994|374